Skip to main content

Natixis

SEC CIK
0001274981
Latest filing
Aug 13, 2026

TBPH holding history

Theravance Biopharma, Inc. in every 13F filed by Natixis, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TBPH overviewAll 13F holders of TBPHFull Q2 2026 holdings

Shares (Q1 2024)
0
Sold out in Q1 2024
Value
$0
% of portfolio
0.0%
Quarters held
2
Since Q3 2023
Holdings of TBPH by Natixis, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20240$00.0%−2,000−100.0%Sold outHolders
Q4 20232,000$22.5K<0.1%00.0%UnchangedHolders
Q3 20232,000$17.3K<0.1%+2,000NewHolders